BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23551429)

  • 1. Clinical significance of vascular endothelial growth factor and vascular endothelial growth factor receptor-2 gene polymorphisms in patients with gastrointestinal stromal tumors.
    Kang BW; Kim JG; Chae YS; Bae HI; Kwon O; Chung HY; Yu W; Song HS; Kang YN; Ryu SW; Lee KH; Bae YK; Choi JH; Kim SW; Ryoo HM; Cho CH; Chae HD; Park KW; Gu MJ; Bae BJ
    Asia Pac J Clin Oncol; 2014 Jun; 10(2):e40-5. PubMed ID: 23551429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with colorectal cancer.
    Kim JG; Chae YS; Sohn SK; Cho YY; Moon JH; Park JY; Jeon SW; Lee IT; Choi GS; Jun SH
    Clin Cancer Res; 2008 Jan; 14(1):62-6. PubMed ID: 18172253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Common polymorphisms in the vascular endothelial growth factor gene and colorectal cancer development, prognosis, and survival.
    Dassoulas K; Gazouli M; Rizos S; Theodoropoulos G; Christoni Z; Nikiteas N; Karakitsos P
    Mol Carcinog; 2009 Jun; 48(6):563-9. PubMed ID: 19009560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic angiogenic markers (endoglin, VEGF, CD31) and tumor cell proliferation (Ki67) for gastrointestinal stromal tumors.
    Basilio-de-Oliveira RP; Pannain VL
    World J Gastroenterol; 2015 Jun; 21(22):6924-30. PubMed ID: 26078569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of intratumoral vascular endothelial growth factor expression and clinical outcome for patients with gastrointestinal stromal tumors treated with imatinib mesylate.
    McAuliffe JC; Lazar AJ; Yang D; Steinert DM; Qiao W; Thall PF; Raymond AK; Benjamin RS; Trent JC
    Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6727-34. PubMed ID: 18006774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of insulin-like growth factor gene polymorphisms with survival in patients with gastrointestinal stromal tumors.
    Kwon O; Chung HY; Yu W; Bae HI; Chae YS; Kim JG; Kang BW; Lee WK
    J Korean Surg Soc; 2012 May; 82(5):288-95. PubMed ID: 22563535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of VEGF and KDR single nucleotide polymorphisms with colorectal cancer susceptibility in Koreans.
    Jang MJ; Jeon YJ; Kim JW; Cho YK; Lee SK; Hwang SG; Oh D; Kim NK
    Mol Carcinog; 2013 Nov; 52 Suppl 1():E60-9. PubMed ID: 23169005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) single nucleotide polymorphisms on outcome in gastroenteropancreatic neuroendocrine neoplasms.
    Berardi R; Torniai M; Partelli S; Rubini C; Pagliaretta S; Savini A; Polenta V; Santoni M; Giampieri R; Onorati S; Barucca F; Murrone A; Bianchi F; Falconi M
    PLoS One; 2018; 13(5):e0197035. PubMed ID: 29787601
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VEGF and VEGFR genotyping in the prediction of clinical outcome for HCC patients receiving sorafenib: the ALICE-1 study.
    Scartozzi M; Faloppi L; Svegliati Baroni G; Loretelli C; Piscaglia F; Iavarone M; Toniutto P; Fava G; De Minicis S; Mandolesi A; Bianconi M; Giampieri R; Granito A; Facchetti F; Bitetto D; Marinelli S; Venerandi L; Vavassori S; Gemini S; D'Errico A; Colombo M; Bolondi L; Bearzi I; Benedetti A; Cascinu S
    Int J Cancer; 2014 Sep; 135(5):1247-56. PubMed ID: 24510746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Germline Polymorphisms of the VEGF Pathway Predict Recurrence in Nonadvanced Differentiated Thyroid Cancer.
    Marotta V; Sciammarella C; Capasso M; Testori A; Pivonello C; Chiofalo MG; Gambardella C; Grasso M; Antonino A; Annunziata A; Macchia PE; Pivonello R; Santini L; Botti G; Losito S; Pezzullo L; Colao A; Faggiano A
    J Clin Endocrinol Metab; 2017 Feb; 102(2):661-671. PubMed ID: 27849428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of VEGF, VEGFR, PDGFR, HIF and ERCC1 gene polymorphisms on thymic malignancies outcome after thymectomy.
    Berardi R; Brunelli A; Pagliaretta S; Paolucci V; Conti A; Goteri G; Refai M; Pompili C; Marcantognini G; Morgese F; Ballatore Z; Savini A; De Lisa M; Caramanti M; Santoni M; Zizzi A; Piva F; Mazzanti P; Onofri A; Sabbatini A; Scarpelli M; Cascinu S
    Oncotarget; 2015 Aug; 6(22):19305-15. PubMed ID: 26254278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular endothelial growth factor (VEGF) and its receptor VEGFR-2 are highly expressed in ovarian granulosa cell tumors.
    Färkkilä A; Anttonen M; Pociuviene J; Leminen A; Butzow R; Heikinheimo M; Unkila-Kallio L
    Eur J Endocrinol; 2011 Jan; 164(1):115-22. PubMed ID: 21041381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular endothelial growth factor polymorphisms in relation to breast cancer development and prognosis.
    Jin Q; Hemminki K; Enquist K; Lenner P; Grzybowska E; Klaes R; Henriksson R; Chen B; Pamula J; Pekala W; Zientek H; Rogozinska-Szczepka J; Utracka-Hutka B; Hallmans G; Försti A
    Clin Cancer Res; 2005 May; 11(10):3647-53. PubMed ID: 15897560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.
    Ravegnini G; Nannini M; Zenesini C; Simeon V; Sammarini G; Urbini M; Gatto L; Saponara M; Biasco G; Pantaleo MA; Venturoli N; Hrelia P; Angelini S
    Angiogenesis; 2017 Feb; 20(1):139-148. PubMed ID: 27896475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
    Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vascular endothelial growth factor gene polymorphisms associated with prognosis for patients with gastric cancer.
    Kim JG; Sohn SK; Chae YS; Cho YY; Bae HI; Yan G; Park JY; Lee MH; Chung HY; Yu W
    Ann Oncol; 2007 Jun; 18(6):1030-6. PubMed ID: 17426061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Influence of the VEGF-A 936C>T germinal polymorphism on tumoral VEGF expression in head and neck cancer.
    Formento JL; Etienne-Grimaldi MC; Francoual M; Pagès G; Onesto C; Formento P; Chamorey E; Dassonville O; Poissonnet G; Milano G
    Pharmacogenomics; 2009 Aug; 10(8):1277-83. PubMed ID: 19663672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of vascular endothelial growth factor gene polymorphisms in patients with colorectal cancer.
    Jang MJ; Kim JW; Jeon YJ; Chong SY; Oh D; Kim NK
    Int J Clin Oncol; 2013 Dec; 18(6):1032-41. PubMed ID: 23132736
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor C and vascular endothelial growth factor receptor 2 are related closely to the prognosis of patients with ovarian carcinoma.
    Nishida N; Yano H; Komai K; Nishida T; Kamura T; Kojiro M
    Cancer; 2004 Sep; 101(6):1364-74. PubMed ID: 15368324
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.